Aptose Biosciences Inc. (NASDAQ: APTO)
$0.71
-0.0004 ( -0.06% ) 79.5K
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
Market Data
Open
$0.71
Previous close
$0.71
Volume
79.5K
Market cap
$12.73M
Day range
$0.69 - $0.73
52 week range
$0.67 - $5.10
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Oct 26, 2023 |
8-k | 8K-related | 14 | Oct 23, 2023 |
8-k | 8K-related | 14 | Oct 16, 2023 |
4 | Insider transactions | 2 | Sep 25, 2023 |
8-k | 8K-related | 14 | Sep 18, 2023 |
8-k | 8K-related | 14 | Sep 12, 2023 |
8-k | 8K-related | 14 | Sep 06, 2023 |
8-k | 8K-related | 14 | Aug 24, 2023 |
8-k | 8K-related | 14 | Aug 10, 2023 |
10-q | Quarterly Reports | 67 | Aug 10, 2023 |